在接受直接抗病毒药物（DAA）治疗后实现持续病毒学应答（SVR）的丙型肝炎病毒/艾滋病病毒（HCV/HIV）合并感染和HCV感染参与者中，HCV复发率相似：美国国立过敏与传染病研究所艾滋病临床试验组A5320病毒性丙型肝炎感染长期队列研究（V-HICS）的中期结果
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
作者信息
Wyles David L, Kang Minhee, Matining Roy M, Murphy Robert L, Peters Marion G
机构信息
Department of Medicine, Denver Health Medical Center, Denver, Colorado.
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
出版信息
Open Forum Infect Dis. 2018 Jun 4;5(6):ofy103. doi: 10.1093/ofid/ofy103. eCollection 2018 Jun.
Abstract
Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for recurrence. Care should be taken not to label all HCV/HIV co-infected patients as being at high risk for HCV recurrence.
摘要
丙型肝炎病毒（HCV）/人类免疫缺陷病毒（HIV）合并感染患者的丙型肝炎病毒复发率（0.35/100人年）与单纯丙型肝炎病毒感染患者（0.42/100人年）相似。复发率低可能是因为纳入了复发风险较低的HIV人群。应注意不要将所有HCV/HIV合并感染患者都标记为丙型肝炎病毒复发的高风险人群。
相似文献
1
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).在接受直接抗病毒药物（DAA）治疗后实现持续病毒学应答（SVR）的丙型肝炎病毒/艾滋病病毒（HCV/HIV）合并感染和HCV感染参与者中，HCV复发率相似：美国国立过敏与传染病研究所艾滋病临床试验组A5320病毒性丙型肝炎感染长期队列研究（V-HICS）的中期结果
Open Forum Infect Dis. 2018 Jun 4;5(6):ofy103. doi: 10.1093/ofid/ofy103. eCollection 2018 Jun.
2
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).在接受直接抗病毒治疗后实现病毒学持续应答的丙型肝炎病毒（HCV）/艾滋病病毒（HIV）合并感染及HCV感染参与者中，HCV复发率持续较低：艾滋病临床试验组A5320病毒性丙型肝炎感染长期队列研究（V-HICS）的最终结果
Open Forum Infect Dis. 2021 Oct 14;8(12):ofab511. doi: 10.1093/ofid/ofab511. eCollection 2021 Dec.
3
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS).HIV-1对丙型肝炎直接抗病毒药物治疗后长期预后的不良影响：丙型肝炎病毒感染长期队列研究（VHICS）ACTG A5320的最终结果
Open Forum Infect Dis. 2023 Mar 6;10(3):ofad115. doi: 10.1093/ofid/ofad115. eCollection 2023 Mar.
4
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care.直接作用抗病毒药物在持续存在治疗障碍的 HIV 感染患者中的丙型肝炎病毒持续应答中的影响。
Open Forum Infect Dis. 2015 Nov 12;2(4):ofv168. doi: 10.1093/ofid/ofv168. eCollection 2015 Dec.
5
Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008-2015.2008 - 2015年两个治疗时期丙型肝炎病毒/艾滋病病毒合并感染与丙型肝炎病毒单一感染患者丙型肝炎连续护理比较
AIDS Res Hum Retroviruses. 2018 Feb;34(2):148-155. doi: 10.1089/AID.2017.0092. Epub 2017 Nov 8.
6
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.在大型基于人群的队列中，使用直接作用抗病毒治疗成功治疗后丙型肝炎病毒再感染。
J Hepatol. 2018 Nov;69(5):1007-1014. doi: 10.1016/j.jhep.2018.07.025. Epub 2018 Aug 22.
7
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.索磷布韦联合利巴韦林无需干扰素治疗HIV-1感染个体的急性丙型肝炎病毒感染：SWIFT-C研究
Clin Infect Dis. 2017 Apr 15;64(8):1035-1042. doi: 10.1093/cid/cix025.
8
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?接受直接抗病毒药物治疗的丙型肝炎病毒（HCV）单感染和人类免疫缺陷病毒/丙型肝炎病毒（HIV/HCV）合并感染个体：他们在多大程度上存在差异？
Int J Infect Dis. 2017 Sep;62:64-71. doi: 10.1016/j.ijid.2017.07.001. Epub 2017 Jul 17.
9
Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.直接作用抗病毒药物时代的丙型肝炎病毒和人类免疫缺陷病毒合并感染：不再是一个难以治疗的人群。
Hepatology. 2018 Mar;67(3):847-857. doi: 10.1002/hep.29642. Epub 2018 Jan 30.
10
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.基于索磷布韦的疗法成功治疗合并感染人类免疫缺陷病毒/丙型肝炎病毒的肝移植受者复发性丙型肝炎病毒感染
AIDS. 2016 Jan 2;30(1):93-8. doi: 10.1097/QAD.0000000000000887.
引用本文的文献
1
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).在接受直接抗病毒治疗后实现病毒学持续应答的丙型肝炎病毒（HCV）/艾滋病病毒（HIV）合并感染及HCV感染参与者中，HCV复发率持续较低：艾滋病临床试验组A5320病毒性丙型肝炎感染长期队列研究（V-HICS）的最终结果
Open Forum Infect Dis. 2021 Oct 14;8(12):ofab511. doi: 10.1093/ofid/ofab511. eCollection 2021 Dec.
2
The risk of hepatitis C virus recurrence in hepatitis C virus-infected patients treated with direct-acting antivirals after achieving a sustained virological response: A comprehensive analysis.直接作用抗病毒药物治疗获得持续病毒学应答后丙型肝炎病毒感染患者复发丙型肝炎病毒的风险：综合分析。
Liver Int. 2021 Oct;41(10):2341-2357. doi: 10.1111/liv.14976. Epub 2021 Jun 16.
3
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression.人类免疫缺陷病毒和嗜肝病毒合并感染作为肝损伤进展的诱导因素。
World J Gastroenterol. 2019 Jan 28;25(4):398-410. doi: 10.3748/wjg.v25.i4.398.
本文引用的文献
1
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.HIV合并感染患者持续病毒学应答后丙型肝炎病毒再感染的危险因素
Clin Infect Dis. 2017 May 1;64(9):1154-1162. doi: 10.1093/cid/cix126.
2
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.在西欧 HIV 阳性男男性行为者中 HCV 再感染发生率和自发清除率。
J Hepatol. 2017 Feb;66(2):282-287. doi: 10.1016/j.jhep.2016.09.004. Epub 2016 Sep 17.
3
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.丙型肝炎病毒获得持续病毒学应答后晚期复发或再感染的风险：一项系统评价和荟萃分析。
Clin Infect Dis. 2016 Mar 15;62(6):683-694. doi: 10.1093/cid/civ948. Epub 2016 Jan 19.
4
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM.HIV 阳性男男性行为者中丙型肝炎病毒再感染发生率和治疗结局。
AIDS. 2013 Oct 23;27(16):2551-7. doi: 10.1097/QAD.0b013e32836381cc.
5
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.HIV 感染的男男性行为者中，经治疗性获得的急性丙型肝炎病毒感染后丙型肝炎病毒再感染的惊人发病率。
AIDS. 2011 Nov 13;25(17):F21-7. doi: 10.1097/QAD.0b013e32834bac44.
6
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection.HIV 感染者中的急性丙型肝炎：一种新出现的性传播感染。
AIDS. 2010 Jul 31;24(12):1799-812. doi: 10.1097/QAD.0b013e32833c11a5.
7
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak?2002年至2006年伦敦和布莱顿男男性行为艾滋病毒阳性者中新诊断出的丙型肝炎新增病例增加：这是一次疫情爆发吗？
Sex Transm Infect. 2008 Apr;84(2):111-5. doi: 10.1136/sti.2007.027334. Epub 2007 Oct 11.
8
Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission.阿姆斯特丹男男性行为者中丙型肝炎病毒发病率的上升很可能是由性传播引起的。
J Infect Dis. 2007 Jul 15;196(2):230-8. doi: 10.1086/518796. Epub 2007 Jun 11.
9
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.近期，与高危性行为相关的男男性行为者感染艾滋病毒后急性丙型肝炎病毒流行。
AIDS. 2007 May 11;21(8):983-91. doi: 10.1097/QAD.0b013e3281053a0c.
10
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.注射吸毒者中丙型肝炎病毒3a亚型的分子流行病学
J Med Virol. 2006 Oct;78(10):1296-303. doi: 10.1002/jmv.20692.
Zotero 插件